Back to results
US 11,110,098 B2Granted
Methods and medicaments for the treatment of renal cell carcinoma
AssigneeUniversity of Kansas
InventorReena Rao
Life of this patent
Estimating the term…
Abstract
The present disclosure is directed, among other things, to the surprising and unexpected efficacy provided by select V2R antagonists in significantly reducing the cell proliferation levels of clear cell renal cell carcinoma. Thus, the present disclosure provides methods, uses, and medicaments that include such select V2R antagonists for utility in treating clear cell renal cell carcinoma.
Claims20
A method of treating a subject suffering from clear cell renal cell carcinoma, the method comprising
- administering to the subject an effective amount of a compound selected from OPC31260, OPC41061, a pharmaceutically acceptable salt of either thereof, or a mixture of any two or more thereof;
- wherein the effective amount is an amount effective for treating clear cell renal cell carcinoma.
Dependencies are inferred from the claim text.